ZE6-81628-80945
4 vaccinations
2 coded responses
35 check-ins
2 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 41-45
- ZIP prefix
- 290 / SC
- Registered
- 2021-05-06
- Relationship
- Self
- Race
- Black or African American
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-15
Dose 1 — Pfizer-BioNTech
-
2021-05-06
Registered in v-safe
-
2021-05-06
Dose 2 — Pfizer-BioNTech
-
2021-05-06
Health check-in — day 0, dose 2Feeling: Fair · Fever · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-05-07
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Muscle or body achesAdult check-in
-
2021-05-08
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain, Swelling · Joint pains, Muscle or body aches · Be unable to do your normal daily activitiesAdult check-in
-
2021-05-09
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Redness, Swelling, Itching · NoneAdult check-in
-
2021-05-10
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Redness, Swelling · NoneAdult check-in
- 2021-05-11
- 2021-05-12
- 2021-05-13
- 2021-05-20
- 2021-05-27
- 2021-06-05
- 2021-06-10
- 2021-06-17
- 2021-08-05
- 2021-11-04
-
2021-12-15
Dose 3 — Pfizer-BioNTech
-
2021-12-17
Survey response — days 1–6 daily, dose 3MedDRA: Lymphadenopathy — Feeling: Fair · Site: Pain, Redness, Swelling · Fever · Chills, Muscle or body aches, Fatigue or tiredness, NauseaFree text: Swollen lymph nodes on side of shotMedDRA releases: 2024-11 · check-in free text available
-
2021-12-19
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain, Redness, Swelling · NoneAdult check-in
- 2021-12-21
- 2021-12-22
- 2021-12-29
- 2022-01-05
- 2022-01-14
- 2022-01-19
-
2022-01-26
Survey response — day 42, dose 3MedDRA: Diabetes mellitus — Feeling: GoodFree text: DiabetesMedDRA releases: 2024-11 · check-in free text available
- 2022-03-16
- 2022-06-15
-
2022-10-04
Dose 4 — Pfizer-BioNTech
- 2022-10-10
- 2022-10-11
- 2022-10-18
- 2022-10-25
- 2022-11-01
- 2022-11-08
- 2022-11-15
- 2023-01-04
- 2023-04-04
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-15 | Pfizer-BioNTech | |
| 2 | 2021-05-06 | Pfizer-BioNTech | |
| 3 | 2021-12-15 | Pfizer-BioNTech | No |
| 4 | 2022-10-04 | Pfizer-BioNTech | No |
Free text
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): Swollen lymph nodes on side of shot
Release 11 — day 42, dose 3
Symptoms: Diabetes
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Diabetes mellitus | · | · | ✓ |
| SRO | Lymphadenopathy | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release